Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by NSX001on Dec 04, 2021 10:17am
274 Views
Post# 34198243

RE:New shares for $13 Million bucks

RE:New shares for $13 Million bucksThis is just my opinion only.

This is a coordinated attack on the price of the shares, someone is accumulating prior to Tetra completing and annoucing their clinical tests. Who ever they are, their very well aware of how well the clinical trials are proceeding, and they want the company a-la-cheap.

Multiple houses are involved in selling and buying umongst themselves, putting downward pressure on the share price, thus dropping the price just enough not to get noticed and frightning small shareholders into selling even more. The end scheme here is "accumulation" for a later buy-out at a much higher price.

There are too many shares out there for their efforts to be noticed, and so they continue their drive to accumulate. If you really believe in this company's future, don't fall for thier attack, don't sell your shares.

Do you really belivef that if other more savvy investors are putting huge amounts of money into this, they would continue to do so if it wasn't going to be profitable for them? Come on guys get real. 

They have stooges on this and other boards/sites sowing douts like, no updates on clinical trials, the company is running out of money, why it's taking so much time. Just a constant barrage of negative innuendoes.

They don't mention the advancements being made or the fact that Health Canadian, US.s FDA and the European Medicines Agency have all given approval to move ahead with their research. That would not happen if this was just a scam./

Trickerry and deceipt is all that these people do, day-in and day-out and their very good at it, so just play there game, if they want these shares so badly, then maybe you should want them also.

NSX001
<< Previous
Bullboard Posts
Next >>